Multiple myeloma: The biology of malignant plasma cells
- 31 March 1993
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 7 (1) , 19-23
- https://doi.org/10.1016/0268-960x(93)90020-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Homotypic cell aggregations of human myeloma cells with ICAM‐1 and LFA‐1 moleculesBritish Journal of Haematology, 1991
- Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cellsBritish Journal of Haematology, 1991
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- Lymphocyte homing receptors cloned — a role for anionic polysaccharides in lymphocyte adhesionImmunology Today, 1989
- Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.The Journal of Experimental Medicine, 1989
- No detectable malignant B cells in the peripheral blood of patients with multiple myelomaBritish Journal of Haematology, 1989
- A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitroBritish Journal of Haematology, 1988
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977